Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study

Treatment-resistant depression (TRD) reduces affected patients’ quality of life and leads to important social health care costs. Pharmacogenomics-guided treatment (PGT) may be effective in the cure of TRD. The main aim of this study was to evaluate the clinical changes after PGT in patients with TRD...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Casale, Antonio, Pomes, Leda Marina, Bonanni, Luca, Fiaschè, Federica, Zocchi, Clarissa, Padovano, Alessio, De Luca, Ottavia, Angeletti, Gloria, Brugnoli, Roberto, Girardi, Paolo, Preissner, Robert, Borro, Marina, Gentile, Giovanna, Pompili, Maurizio, Simmaco, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874425/
https://www.ncbi.nlm.nih.gov/pubmed/35207804
http://dx.doi.org/10.3390/jpm12020316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874425/
https://www.ncbi.nlm.nih.gov/pubmed/35207804
http://dx.doi.org/10.3390/jpm12020316

Ejemplares similares